|4Dec 5, 5:59 PM ET

GRAHAM RICHARD A 4

4 · Theravance Biopharma, Inc. · Filed Dec 5, 2022

Insider Transaction Report

Form 4
Period: 2022-12-01
GRAHAM RICHARD A
SVP, Development
Transactions
  • Sale

    Ordinary Shares

    2022-12-01$10.73/sh2,084$22,361313,520 total

Documents

1 file
  • 4
    form4-12052022_101216.xmlPrimary